Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
21.66
-1.30 (-5.66%)
At close: May 7, 2026
Market Cap4.39B -11.5%
Revenue (ttm)n/a
Net Income-167.32M
EPS-0.84
Shares Out198.91M
PE Ration/a
Forward PE38.39
Dividendn/a
Ex-Dividend Daten/a
Volume3,000
Average Volume12,970
Open22.66
Previous Close22.96
Day's Range21.00 - 22.66
52-Week Range20.00 - 28.00
Beta-0.69
RSI40.30
Earnings DateMay 26, 2026

About HKG:2480

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China. Its clinical-stage product candidates include LZ901, a recombinant herpes zoster vaccine, which completed Phase III clinical trial; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection product for the treatment of various autoimmune diseases,... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 193
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2480
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements